combination therapy with glp-1 receptor agonist and sglt2 inhibitor Inhibitors Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application SGLT-2 inhibitors, GLP-1 receptor agonists,
Description
& Leibel, R
It works by mimicking the action of the GLP-1 hormone, which regulates appetite and food intake
Qsymia combines two older, well-established medications (phentermine from 1959, topiramate from 1996)
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: A retrospective study
doi: 10.1124/jpet.119.258343
Weighing In on Obesity and Psoriatic Arthritis Time to Move Beyond Association to Robust Randomised Trials
